| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.79B | +6.0% |
| Cost of Revenue | $1.48B | +8.8% |
| Gross Profit | $308.6M | -5.3% |
| R&D Expense | $25.9M | -10.6% |
| SG&A Expense | $143.1M | -1.7% |
| Operating Income | $109.8M | +132.5% |
| Pre-tax Income | $81.5M | +447.2% |
| Income Tax | $6.7M | -25.5% |
| Net Income | $74.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -18.1% |
| Accounts Receivable | $222.9M | +15.0% |
| Inventory | $461.2M | +4.5% |
| Current Assets | $789.5M | +9.0% |
| Total Assets | $1.80B | +6.2% |
| Current Liabilities | $253.6M | +11.8% |
| Long-term Debt | $460.6M | +3.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $103.2M | +17.6% |
| Investing Cash Flow | -$98.1M | -23.3% |
| Financing Cash Flow | -$9.8M | -134.6% |
| +1170.8% |
| EPS (Basic) | $3.61 | +1189.3% |
| EPS (Diluted) | $3.58 | +1178.6% |
| Stockholders' Equity |
| $943.3M |
| +8.6% |